Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Surfactant replacement therapy]

M H Miyoshi1

  • 1Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil.

Jornal De Pediatria
|December 17, 2003
PubMed
Summary
This summary is machine-generated.

Surfactant replacement therapy is standard care for neonatal respiratory distress syndrome, improving lung function and reducing mortality. Its effectiveness in other infant lung diseases requires further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The recognition of facial expression of pain in full-term newborns by parents and health professionals.

Archives of pediatrics & adolescent medicine·2000
Same author

Physiological, hormonal, and behavioral responses to a single fentanyl dose in intubated and ventilated preterm neonates.

The Journal of pediatrics·1998
Same author

[Pain in intubated and ventilated preterm neonate: multidimensional assessment and response to fentanyl analgesia].

Jornal de pediatria·1994
Same journal

Acetaminophen versus Ibuprofen for the management of hemodynamically significant patent ductus arteriosus in very low birth weight infants: randomized trial.

Jornal de pediatria·2026
Same journal

Cross-cultural adaptation into Brazilian Portuguese of an international questionnaire for the assessment of cardiopulmonary resuscitation knowledge among adolescents.

Jornal de pediatria·2026
Same journal

Evaluation of ChatGPT's reliability in answering questions about short stature and growth failure.

Jornal de pediatria·2026
Same journal

Validity of the Khamis-Roche method, relative to bone age, in Portuguese children and adolescents from 11 to 15 years.

Jornal de pediatria·2026
Same journal

Urogenital congenital anomalies in children under 9 years: global disease burden analysis and projections, 1990-2021.

Jornal de pediatria·2026
Same journal

Intraventricular hemorrhage in preterm newborns: a multicenter study in four Brazilian hospitals.

Jornal de pediatria·2026
See all related articles

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Critical Care

Background:

  • Neonatal lung diseases pose significant challenges.
  • Surfactant deficiency is a key factor in respiratory distress syndrome.
  • Exogenous surfactant therapy aims to restore lung function.

Purpose of the Study:

  • To update information on surfactant replacement therapy for neonatal lung diseases.
  • To analyze the efficacy and limitations of current surfactant treatments.
  • To explore potential future applications of surfactant therapy.

Main Methods:

  • Comprehensive literature review.
  • Inclusion of various study types: meta-analyses, RCTs, case studies.
  • Analysis based on clinical and scientific expertise.

Related Experiment Videos

Main Results:

  • Surfactant therapy improves respiratory function in neonatal respiratory distress syndrome.
  • It reduces oxygen and ventilation support needs and air leak syndrome.
  • Neonatal mortality decreased by up to 40% with surfactant treatment.
  • Effectiveness in other conditions like meconium aspiration syndrome is not widely established.

Conclusions:

  • Surfactant replacement is the established standard for neonatal respiratory distress syndrome.
  • Further research into synthetic surfactants may broaden therapeutic applications.
  • Optimizing surfactant therapy for diverse neonatal respiratory conditions remains an ongoing goal.